Fatal diffuse pulmonary arterial thrombosis as a complication of nephrotic syndrome
Tóm tắt
A 21-year-old man was admitted to our hospital because of leg edema. Because laboratory findings revealed massive proteinuria and hypoproteinemia, he was diagnosed as having nephritic syndrome caused by minimal change disease. He was given a continuous heparin infusion and intravenous steroid therapy, at a prednisolone dose of 1 mg/kg per day, and his condition gradually improved. Five months after discharge, the patient's proteinuria relapsed. He was readmitted to our hospital and we restarted anticoagulant treatment with intravenous heparin and 60 mg prednisolone. On the third hospital day, he complained of chest pain with sudden onset and dyspnea. He quickly developed shock and died. The findings of an autopsy confirmed the presence of diffuse fibrin thrombi in bilateral pulmonary arteries, and we diagnosed the cause of death as diffuse pulmonary artery thrombosis. A coagulation test for activated partial thromboplastin time (aPTT) had already shown that aPTT was prolonged before the initiation of treatment. There may have been a deficit of antithrombin III (ATIII) – a cofactor of heparin – because of the proteinuria; thus, the continuous heparin treatment might not have been effective for the prevention of thrombosis. Alternatives to heparin treatment that do not suppress AT III, such as nafamostat mesilate or argatroban, which do not require the presence of AT III for their anticoagulant action, should be considered in cases similar to the that in the patient reported here. In patients with nephrotic syndrome who exhibit altered coagulation test results, the choice of anticoagulation therapy for treatment of the hypercoagulabilty status associated with nephrotic syndrome should be carefully considered.
Tài liệu tham khảo
Y Etho I Ohsawa T Fujita Y Fuke M Endo H Ohi et al. (2002) ArticleTitleNephrotic syndrome with portal, splenic and renal vein thrombosis Nephron 92 680–4 Occurrence Handle10.1159/000064107
F Llach (1985) ArticleTitleHypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome Kidney Int 28 429–39 Occurrence Handle1:STN:280:DyaL28%2FmtlKkuw%3D%3D Occurrence Handle10.1038/ki.1985.149 Occurrence Handle3906225
K Kaizu S Etho (1998) ArticleTitleNephrotic syndrome and anticoagulant therapy Intern Med 37 210–2 Occurrence Handle1:STN:280:DyaK1c3gvF2rtg%3D%3D Occurrence Handle10.2169/internalmedicine.37.210 Occurrence Handle9550613
K Shimamatsu K Onoyama T Maeda F Ohryoji S Fujimi T Omae (1982) ArticleTitleMassive pulmonary embolism occurring with corticosteroid and diuretics therapy in a minimal-change nephrotic patient Nephron 32 78–9 Occurrence Handle1:STN:280:DyaL3s%2FovFWnuw%3D%3D Occurrence Handle10.1159/000182809 Occurrence Handle7177283
RL Zimmerman S Novek JTT Chen V Roggli (1994) ArticleTitlePulmonary thrombosis in a 10-year-old child with minimal change disease and nephritic syndrome Am J Clin Pathol 101 230–6 Occurrence Handle1:STN:280:DyaK2c7mtV2mtw%3D%3D Occurrence Handle10.1093/ajcp/101.2.230 Occurrence Handle8116580
K Ahmed E Saeed (1995) ArticleTitleNephrotic syndrome and pulmonary artery thrombosis Am J Nephrol 15 274–6 Occurrence Handle1:STN:280:DyaK2Mzktl2nuw%3D%3D Occurrence Handle10.1159/000168846 Occurrence Handle7618656
PV Deshpande M Griffiths (2005) ArticleTitlePulmonary thrombosis in steroid-sensitive nephritic syndrome Pediatr Nephrol 20 665–9 Occurrence Handle10.1007/s00467-004-1741-4 Occurrence Handle15778847
A Rasool PM Palevsdy (2000) ArticleTitleTreatment of edematous disorders with diuretics Am J Med Sci 319 25–37 Occurrence Handle1:STN:280:DC%2BD3c7hslWltQ%3D%3D Occurrence Handle10.1016/S0002-9629(15)40677-9 Occurrence Handle10653442
D Green J Arruda G Honig RC Muehrche (1976) ArticleTitleUrinary loss of clotting factors due to hereditary membranous glomerulopathy Am J Clin Pathol 65 376–83 Occurrence Handle1:STN:280:DyaE287lvVShsA%3D%3D Occurrence Handle10.1093/ajcp/65.3.376 Occurrence Handle1258829
ND Vaziri HE Branson R Ness (1980) ArticleTitleChanges of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome Am J Med Sci 280 167–71 Occurrence Handle1:STN:280:DyaL3M7gs1KqsQ%3D%3D Occurrence Handle10.1097/00000441-198011000-00005 Occurrence Handle6779630
AG Kendall RC Lohmann JB Dossetor (1971) ArticleTitleNephrotic syndrome. A hypercoagulable state Arch Intern Med 127 1021–7 Occurrence Handle1:STN:280:DyaE3M3gtl2gsQ%3D%3D Occurrence Handle10.1001/archinte.1971.00310180037003 Occurrence Handle5578557
RH Kauffmann JJ Veltkamp NH Van Tilburg LA Van Es (1978) ArticleTitleAcquired antithrombin III deficiency and thrombosis in the nephrotic syndrome Am J Mek 65 607–13 Occurrence Handle1:STN:280:DyaE1M%2FjvFegtg%3D%3D Occurrence Handle10.1016/0002-9343(78)90848-3
SH Goodnight JH Griffin (2001) Hereditary thrombophilia E Beutler MA Lichtman B Coller T Kipps U Seligsohn (Eds) Williams hematology EditionNumber6th ed McGraw-Hill New York
LB Menajovsky (2005) ArticleTitleHeparin-induced thrombocytopenia: clinical manifestations and management strategies Am J Med 118 IssueIDSuppl 8A 21S–30S Occurrence Handle1:CAS:528:DC%2BD2MXpvVahsLY%3D Occurrence Handle10.1016/j.amjmed.2005.06.005 Occurrence Handle16125511
A Davorn RH Aster (2006) ArticleTitleHeparin-induced thrombocytopeia and thrombosis Am J Hematol 81 36–44 Occurrence Handle10.1002/ajh.20490